Company attributes
Industry
Location
B2X
0
CEO
Number of Employees (Ranges)
1 – 100
Investors
Founded Date
2020
Total Funding Amount (USD)
3,000,000
Latest Funding Round Date
April 1, 2022
Latest Funding Type
Patents Assigned (Count)
1
Other attributes
Company Operating Status
Active
Funding Round Date
April 27, 2022
Funding Round Amount (USD)
3,000,000
Funding Type
Latest Funding Round Amount (USD)
3,000,000
Bionter operates as a company with the purpose of revolutionizing analytical testing for the benefit of people's health.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
